You just read:

Biohaven Enrolls First Patient In Pivotal Trial Of Trigriluzole In Patients With Obsessive-Compulsive Disorder

News provided by

Biohaven Pharmaceutical Holding Company Ltd.

Dec 21, 2017, 02:00 EST